Patent intelligence · US
US 9901606
Euglena lysate composition
Euglena lysate composition
Patent details — US 9901606
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 27, 2018
- Expiration
- Feb 22, 2038
- Applicant
- ALGAEON, INC.
- Claims
- 26
- CPC classes
- A61K, A61K31/716, A61K33/30, A61K36/02
Quick answer
US 9901606 (Euglena lysate composition) is held by ALGAEON, INC.. Status: granted. Granted Feb 27, 2018. Expires Feb 22, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALGAEON, INC.
- Grant date
- Expiration
- Claims
- 26
- CPC classes
- A61K, A61K31/716, A61K33/30, A61K36/02, A61K45/06, A61K8/73
More from ALGAEON, INC.
Related pharmaceutical patents in our USPTO index.
-
US 11911455
HPV therapeutic nucleic acid vaccine
granted -
US 11826405
Neurotoxin compositions for use in treating headache
granted -
US 9274109
Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
granted -
US 9201072
Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
granted -
US 9149542
Microvesicles derived from cell protoplast and use thereof
granted -
US 9084830
Microvesicles derived from cell protoplast and use thereof
granted -
US 8969653
Extracellular vesicles derived from gram-positive bacteria, and use thereof
granted
Frequently asked questions
What is US patent 9901606?
US 9901606 (Euglena lysate composition) is held by ALGAEON, INC.. Status: granted. Granted Feb 27, 2018. Expires Feb 22, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9901606?
ALGAEON, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 9 pharmaceutical patents for this assignee.
When does US 9901606 expire?
Our index shows an expiration date of Feb 22, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.